Absci Investor Presentation Deck

ABSCI'S END-TO-END PLATFORM SOLUTION The leading Al platform for Al-enabled biologics drug creation Find patient cohort specific targets ↓ Novel target discovery ai. ABSCI CORPORATION 2023 ALL RIGHTS RESERVED Discover novel antibodies for selected target ↓ De novo discovery in silico EB ai. Optimize antibodies' characteristics ↓ Lead optimization in silico ai. y Incorporate site-specific chemical handles Bionic SoluPro™ strain OPTIMAL DRUG CANDIDATE absci. 34

View entire presentation